Chapter 118. Infective Endocarditis (Part 14)

Antibiotic prophylaxis, if 100% effective, likely prevents only a small number of cases of endocarditis; nevertheless, it is possible that rare cases are prevented. Weighing the potential benefits, potential adverse events, and costs associated with antibiotic prophylaxis, the expert committee of the American Heart Association has dramatically restricted the recommendations for antibiotic prophylaxis. Prophylactic antibiotics (Table 118-7) are advised only for those patients at highest risk for severe morbidity or death from endocarditis (Table 1188). Prophylaxis is recommended only for dental procedures wherein there is manipulation of gingival tissue or the periapical region of the teeth or perforation of...
Nội dung trích xuất từ tài liệu:
Chapter 118. Infective Endocarditis (Part 14) Chapter 118. Infective Endocarditis (Part 14) Antibiotic prophylaxis, if 100% effective, likely prevents only a smallnumber of cases of endocarditis; nevertheless, it is possible that rare cases areprevented. Weighing the potential benefits, potential adverse events, and costsassociated with antibiotic prophylaxis, the expert committee of the AmericanHeart Association has dramatically restricted the recommendations for antibioticprophylaxis. Prophylactic antibiotics (Table 118-7) are advised only for thosepatients at highest risk for severe morbidity or death from endocarditis (Table 118-8). Prophylaxis is recommended only for dental procedures wherein there ismanipulation of gingival tissue or the periapical region of the teeth or perforationof the oral mucosa (including surgery on the respiratory tract). Althoughprophylaxis is not advised for patients undergoing gastrointestinal or genitourinarytract procedures, it is recommended that effective treatment be given to these high-risk patients before or when they undergo procedures on an infected genitourinarytract or on infected skin and related soft tissue. Maintaining good dental hygiene isalso advised. (For further details, seehttp://www.americanheart.org/presenter.jhtml?identifier=3047083.) Table 118-7 Antibiotic Regimens for Prophylaxis of Endocarditis inAdults with High-Risk Cardiac Lesionsa,b A. Standard oral regimen 1. Amoxicillin 2.0 g PO 1 h before procedure B. Inability to take oral medication 1. Ampicillin 2.0 g IV or IM within 1 h before procedure C. Penicillin allergy 1. Clarithromycin or azithromycin 500 mg PO 1 h before procedure 2. Cephalexinc 2.0 g PO 1 h before procedure 3. Clindamycin 600 mg PO 1 h before procedure D. Penicillin allergy, inability to take oral medication 1. Cefazolinc or ceftriaxonec 1.0 g IV or IM 30 min before procedure 2. Clindamycin 600 mg IV or IM 1 h before procedure a Dosing for children: for amoxicillin, ampicillin, cephalexin, or cefadroxil,use 50 mg/kg PO; cefazolin, 25 mg/kg IV; clindamycin, 20 mg/kg PO, 25 mg/kgIV; clarithromycin, 15 mg/kg PO; gentamicin, 1.5 mg/kg IV or IM; andvancomycin, 20 mg/kg IV. b For high-risk lesions, see Table 118-8. Prophylaxis is not advised for otherlesions. c Do not use cephalosporins in patients with immediate hypersensitivity(urticaria, angioedema, anaphylaxis) to penicillin. Source: W Wilson et al: Circulation, published online 4/19/07. Table 118-8 High-Risk Cardiac Lesions for Which EndocarditisProphylaxis Is Advised before Dental Procedures Prosthetic heart valves Prior endocarditis Unrepaired cyanotic congenital heart disease, including palliative shunts orconduits Completely repaired congenital heart defects during the 6 months afterrepair Incompletely repaired congenital heart disease with residual defectsadjacent to prosthetic material Valvulopathy developing after cardiac transplantation Source: W Wilson et al: Circulation, published online 4/19/07. Further Readings Baddour LM et al: Diagnosis, antimicrobial therapy, and management ofcomplications. A statement for healthcare professionals from the Committee onRheumatic Fever, Endocarditis, and Kawasaki Disease, Council on CardiovascularDisease in the Young, and the Councils on Clinical Cardiology, Stroke, andCardiovascular Surgery and Anesthesia, American Heart Association. Circulation111:e394, 2005 Durack DT (ed): Infective endocarditis. Infect Dis Clin North Am 16:255,2002 Fowler VG Jr et al: Endocarditis and intravascular infections, in Principlesand Practice of Infectious Diseases, 6th ed, GL Mandell et al (eds). Philadelphia,Elsevier Churchill Livingstone, 2005, pp 975–1021 Horstkotte D et al: Guidelines on prevention, diagnosis and treatment ofinfective endocarditis. Executive summary, The Task Force on InfectiveEndocarditis of the European Society of Cardiology. Eur Heart J 25:267, 2004[PMID: 14972429] Karchmer AW: Infective endocarditis, in Heart Disease, 8th ed, EBraunwald et al (eds). Philadelphia, Elsevier Saunders, 2007, in press ———, Longworth DL: Infections of intracardiac devices. Cardiol Clin21:253, 2003 Li JS et al: Proposed modifications to the Duke criteria for the diagnosis ofinfective endocarditis. Clin Infect Dis 30:633, 2000 [PMID: 10770721] Moreillon P, Que YA: Infective endocarditis. Lancet 363:139, 2004[PMID: 14726169] Morris AJ et al: Bacteriological outcome after valve surgery for activeinfective endocarditis: Implications for duration of treatment after surgery(abstract). Clin Infect Dis 41:187, 2005 [PMID: 15983914] Vikram HR et al: Impact of valve surgery on 6-month mortality in adultswith complicated, left-sided native valve endocarditis: A propensity analysis.JAMA 290:3207, 2003 [PMID: 14693873] Wilson W et al: Prevention of infective endocarditis. Guidelines from theAmerican Heart Association. A guideline from the American Heart AssociationRheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council onCardiovascular Disease in the Young, and the Council on Clinical Cardiology,Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care andOutcomes Research Interdisciplinary Working Group. Circulation, April 19, 2007(epub ahead of print)(http://www.americanheart.org/presenter.jhtml?identifier=3047083) ...